Ac
Achilles (BMS)
London UKFounded 2016100 employees
Private CapbiotechAcquiredOncology
Platform: cNeT Neoantigen
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ACH-7772 | ACH-7772 | Phase 1 | 1 | C5 | ETEwing Sarcoma | ||
| Mavutenlimab | ACH-9795 | Phase 2 | 2 | EGFR | MelanomaPompe |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)